ACTRN12621000697886
Completed
未知
Pilot Study of Incidence of Major Adverse Cardiac Events and Effectiveness of Stent Delivery after Intravascular Lithotripsy Catheter Balloon for Calcified Coronary Artery in Adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Calcified coronary artery
- Sponsor
- Mackay Hospital and Health Service
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Troponin must be less than or equal to the upper limit of lab normal value within 24 hours prior to the procedure or if troponin is elevated, concomitant CK must be normal
- •The target vessel must have a TIMI flow 3 at baseline
- •Patients with significant (\> 50% diameter stenosis) native coronary artery disease including stable or unstable angina and silent ischemia, suitable for PCI
- •Ability to tolerate dual antiplatelet agent (i.e. aspirin, clopidogrel, prasugrel, or ticagrelor for 1 year and single antiplatelet therapy for life
- •Single lesion stenosis of protected LMCA, or LAD, RCA or LCX artery \> 50% in a reference vessel of 2\.5mm – 4\.0 mm diameter and \< 32 mm length
- •Presence of calcification within the lesion on both sides of the vessel as assessed by angiography
- •Planned treatment of single lesion in one vessel
- •Ability to pass a 0\.014’’ guide wire across the lesion
- •Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study\-mandated procedures
- •Patient is able and willing to comply with all assessments in the study
Exclusion Criteria
- •Concomitant use of other techniques to deal CAC such as atherectomy and special balloons
- •Severe renal failure
- •Severe anaemia
- •Previous PCI within 30 days of planned procedure
- •Patients not suitable for consenting such as severe memory impairment
- •Acute coronary syndrome within 1 month from planned procedure
- •Severe Heart Failure (NYHA III or IV)
- •Unable to tolerate dual antiplatelet agents (Aspirin \+ clopidogrel or ticargrelor or prasugrel) for 1 year for any reason
- •Contrast allergy
- •Active infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Study of the Incidence of Myocardial Injury after Non cardiac Surgery in Non-dipper Hypertensive Patients: a single-center prospective observational study.Myocardial injury after non cardiac surgeryJPRN-UMIN000050497Chiba university40
Recruiting
Phase 3
Colchicine effects on Major Adverse Cardiac Events in patients who underwent PCIIRCT20230801059005N1Shiraz University of Medical Sciences204
Recruiting
Not Applicable
Associations between Major Adverse Cardiac Events and Various Parameters in Patients with Cardiovascular Diseases with or without Cardiac RehabilitatioCardiovascular diseaseJPRN-UMIN000016668Department of Cardiology, Fukuoka University School of Medicine.400
Recruiting
Not Applicable
A prospective study in acute cardioembolic strokeDiseases of the nervous systemKCT0000340Asan Medical Center2,000
Active, not recruiting
Phase 1
A multi-center cardiac safety study of subjects who participated in Organon sponsored Phase 1 and Phase 2 completed and discontinued trials with Org 24448 (Protocols: 22601;22602;22603; 153001;153002;153003;153004, 29402; III.04.0311).EUCTR2007-001611-32-NLV Organon295